Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +127.0% | +102.9% | 3 / 3 | +51.1% | +1.79 pp | +1.22 pp | +13.3% | 0.53 | 4.98 | 213 | +51,1% | 7,7 | +127,0% | 4.98 | 8.58 | −42,0% |
| Pts | 12 | 12 | 12 | 12 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 7.400 (close price on 2026-10-16)EPS (TTM): 1.486
Financial charts
1.Revenue & growth
VND bn213Q2/26
1.Revenue & growth
VND bn213Q2/26
2.Profit & growth
VND bn7,74Q2/26
3.Profit mix (Penman)
VND bn20,0Q2/26
4.Margins & cost structure
%12.9%Q2/26
5.Returns & cash cycle
% · days10.4%Q2/26
6.Earnings quality & cash
VND bn74,1Q2/26
7.Asset structure
VND bn303Q2/26
8.Funding & debt health
VND bn · times303Q2/26
9.Revenue backlog
VND bn10,2Q2/26
10.Valuation
times · %5,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %718Q2/26
Adjusted EPS growth, latest quarter
127%
Average adjusted EPS growth, 3 quarters
103%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26